Design of experiments in optimization and validation of hydrophilic interaction liquid chromatography method for determination of amlodipine besylate and its impurities

• Autorzy: Kasagić-Vujanović I. , Knežević D.

Identyfikatory

DOI

10.1556/1326.2020.00875

• Języki publikacji: EN

Abstrakty

EN

A new and rapid hydrophilic interaction liquid chromatographic method has been developed for the quantitative analysis of amlodipine besylate and its specific impurities (D, E, and F). For development of this method, a systematic approach which includes Design of Experiments methodology was applied. For the method optimization, Box–Behnken design and specific way Derringer’s desirability function were applied. They provided identification of the optimal chromatographic conditions on the basis of obtained mathematical models and graphical procedures (three D graphs). The optimal chromatographic conditions were the analytical column ZORBAX NH2 (250 3 4.6 mm, 5 mm particle size); mobile phase consisted of acetonitrile-water phase (50 mM ammonium acetate, pH adjusted to 4.0 with glacial acetic acid) (90.5:9.5 v/v); column temperature 30 8C, mobile phase flow rate 1 mL min1, wavelength of detection 230 nm. As other validation parameters were also found to be suitable, the possibility to apply the proposed method for the determination of amlodipine besylate and its impurities in any laboratory under different circumstances has been proven.

Słowa kluczowe

EN

amlodipine; HILIC; design of experiment; Derringer’s desirability function

• Wydawca: University of Silesia in Katowice ; Akademiai Kiado
• Czasopismo: Acta Chromatographica
• Rocznik: 2022
• Tom: Vol. 34, no. 1
• Strony: 41--52
• Opis fizyczny: Bibliogr. 25 poz., rys., tab.

Twórcy

autor

Kasagić-Vujanović I.

• Department of Pharmacy, Faculty of Medicine, University of Banja Luka, Save Mrkalja 14, 78000 Banja Luka, Bosnia and Herzegovina

• https://orcid.org/0000-0001-7196-4008

autor

Knežević D.

• Department of Pharmacy, Faculty of Medicine, University of Banja Luka, Save Mrkalja 14, 78000 Banja Luka, Bosnia and Herzegovina

Bibliografia

• 1. Brereton, R. G. Chemometrics – Data Analysis for the Laboratory and Chemical Plant. John Wiley & Sons Ltd, The Atrium: Chichester, 2003, pp 1–19.
• 2. Massart, D. L.; Vandeginste, B. G. M.; Buydens, L. M. C.; De Jong, S.; Lew, P. J.; Smeyers–Verbeke, J. Handbook of Chemometrics and Qualimetrics: Part A. Elsevier: Amsterdam, 1997, pp 121–51.
• 3. Massart, D. L.; Vandeginste, B. G. M.; Deming, S. N.; Michotte, Y.; Kaufman, L. Chemometrics: A Textbook, Eslevier Science Publishers BV: Amsterdam, 2003, pp 5–10.
• 4. Araujo, P. W.; Brereton, R. G. Trends. Anal. Chem. 1996, 15, 63–70. https://doi.org/10.1016/0165-9936(96)80762-X.
• 5. Rayan, T. P. Modern Experimental Design; John Wiley & Sons Inc: Hoboken, New Jersey, 2007, pp 13–8.
• 6. Amstrong, N. A. Pharmaceutical Experimental Design and Interpretation; Taylor & Francis Group: Boca Raton, USA, 2006, pp 41–52.
• 7. Ferreira, S. L. C.; Bruns, R. E.; Da Silva, E. G. P.; Dos Santos, W. N. L.; Quintella, C. M.; David, J. M.; De Andrade, J. B.; Breitkreitz, M. C.; Jardim, I. C. S. F.; Neto, B. B. J. Chromatogr. A. 2007, 1158, 2–14. https://doi.org/10.1016/j.chroma.2007.03.051.
• 8. Safa, F.; Hadjmohammadi, M. R. J. Chromatogr. A. 2005, 1078, 42–50. https://doi.org/10.1016/j.chroma.2005.04.081.
• 9. Sivakumar, T.; Manavalan, R.; Valliappan, K. Acta. Chromatogr. 2007, 19, 29– 47. https://pdfs.semanticscholar.org/2725/235f8e8fe39d4b780d16bb32fd1bab4d706b.pdf.
• 10. D’Hondt, M.; Verbeke, F.; Stalmans, S.; Gevaert, B.; Wynendaele, E.; De Spiegeleer, B. J. Pharm. Analysis. 2014, 4, 173–82. https://doi.org/10.1016/j.jpha.2013.09.001.
• 11. Jeong, I. J.; Kim, K. J. Eur. J. Oper. Res. 2009, 195, 412–26. https://doi.org/10.1016/j.ejor.2008.02.018.
• 12. Sivakumar, T.; Manavalant, R.; Muralidharan, C.; Valliappan, K. J. Pharm. Biomed. Anal. 2007, 43, 1842–8. https://doi.org/10.1016/j.jpba.2006.12.007.
• 13. Buszewski, B.; Noga, S. Anal. Bioanal. Chem. 2012, 402, 231–47. https://dx.doi.org/10.1007%2Fs00216-011-5308-5.
• 14. Rang, H. P.; Ritter, J. M.; Flower, R. J.; Henderson, G. Rang and Dale’s Pharmacology, 8th ed.; Churchill Livingstone: London, 2015,p 265.
• 15. European Pharmacopoeia 9th ed.; European Directorate for the Quality of Medicines and HealthCare (EDQM & HealthCare), Council of Europe: Strasbourg, France, 2017, p 1547.
• 16. Dai, S. Y.; Qiu, S. T.; Wu, W.; Fu, C. M. J. Pharm. Anal. 2013, 3, 440–6. https://doi.org/10.1016/j.jpha.2013.09.002.
• 17. Jaivik, V. S.; Jignesh M. P.; Priyanka, A. S.; Priya, V. S.; Mallika, S. ; Pranav, S. S. J. Pharm. Anal. 2017, 7, 309–16. https://doi.org/10.1016/j.jpha.2017.06.001.
• 18. Vojta, J. ; Jedlička, A. ; Coufal, P. ; Janečkova, L. J. Pharm. Biomed. Anal. 2015, 109, 36–44. https://doi.org/10.1016/j.jpba.2015.01.059.
• 19. Sangeetha, D.; Vadlamudi, M. K. J. Liq. Chromatogr. Relat. Technol. 2017, 40, 576–98. https://doi.org/10.1080/10826076.2017.1334215.
• 20. El-Bagary, R. I.; Elkady, E. F.; Mowaka, S.; Attallah, M. A.; J. AOAC. Int. 2017, 100, 992–9. https://doi.org/10.5740/jaoacint.16-0279.
• 21. Courlet, P.; Spaggiari, D.; Desfontaine, V.; Cavassini, M.; Alves Saldanha, S.; Buclin,T.; Marzolini, C.; Csajka, C.; Decosterd, L.A. J. Chromatogr. B. 2019, 1125, 121733. https://doi.org/10.1016/j.jchromb.2019.121733.
• 22. Kasagić-Vujanović, I. ; Jančić-Stojanović, B. J. Pharm. Biomed. Anal. 2019, 173, 86–95. https://doi.org/10.1016/j.jpba.2019.05.026.
• 23. Derringer, G.; Suich, R. J. Qual. Technol. 1980, 12, 214–9. https:// doi.org/10.1080/00224065.1980.11980968.
• 24. Malenović, A. ; Dotsikas, Y. ; Mašković, M. ; Jančić-Stojanović, B. ; Ivanović, D. ; Medenica, M. Microchem. J. 2011, 99, 454–460. https://doi.org/10.1016/j.microc.2011.06.022.
• 25. Vander Heyden, Y.; Nijhuis, A.; Smeyers-Verbeke, J.; Vandeginste, B.; Massart, D. J. Pharm. Biomed. Anal. 2001, 24, 723–53. https://doi.org/10.1016/S0731-7085(00)00529-X. Open Access.

Uwagi

Opracowanie rekordu ze środków MEiN, umowa nr SONP/SP/546092/2022 w ramach programu "Społeczna odpowiedzialność nauki" - moduł: Popularyzacja nauki i promocja sportu (2022-2023).